Consumer Health Neurology
WHO Grants ‘Emestedastat’ as the Official INN for Actinogen’s Xanamem®, a First-in-Class Cortisol Regulator
Actinogen Medical Limited (ASX: ACW) has announced that the World Health Organization (WHO) has granted the nonproprietary name ‘emestedastat...
February 06, 2025 | News
Argent BioPharma’s CannEpil® Offers New Hope for Drug-Resistant Epilepsy Patients
Argent BioPharma Limited (ASX: RGT) (OTCQB: RGTLF), a clinical-stage biopharmaceutical company, is pioneering a transformative approach to drug-resistant e...
February 06, 2025 | News
Corcept Therapeutics Submits NDA for Relacorilant to FDA for Cushing’s Syndrome Treatment
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocr...
January 01, 2025 | News
GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...
December 12, 2024 | News
Actinogen Expands Alzheimer’s Trial Across Australia and US, Eyes Interim Results in 2025
Late-stage trial in Alzheimer's opens 10 sites in US, with results due in 2025 and 2026 Appoints US-based Chief Commercial Officer, Andrew Udell X...
December 10, 2024 | News
SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center
MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...
December 10, 2024 | News
Alamar Biosciences Expands to APAC with ARGO™ HT System Installation at HKCeND
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is proud to announce its commercial presence in th...
December 09, 2024 | News
ShiraTronics Launches Pivotal RELIEV-CM2 Trial with First Neuromodulation Implants for Chronic Migraine in the U.S. and Australia
First Implants of Innovative Device Completed in the United States and Australia ShiraTronics, a clinical-stage innovator in neuromodulatio...
December 04, 2024 | News
Serina Therapeutics Secures $10 Million Equity Financing from JuvVentures to Advance Parkinson's Therapy
Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company, announced a $10 million equity fi...
December 03, 2024 | News
Eisai and Biogen Japan Partner with NCNP for APOE Genetic Testing in Alzheimer’s Research
Eisai Co., Ltd. and Biogen Japan Ltd. announced that Eisai has entered into a research collaboration agreement with the National Center of Neurology and Ps...
November 27, 2024 | News
HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Complete Phase 1 Study of HL192 (ATH-399A) for Parkinson’s Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported...
November 26, 2024 | News
ReviR Therapeutics Secures Kennedy’s Disease Association Grant to Advance Therapy for Rare Neuromuscular Disorder
ReviR Therapeutics, a pioneering biotechnology company focused on developing novel small molecule RNA modulators for neurogenetic diseases, announced a gro...
November 26, 2024 | News
Eisai Launches Rozebalamin® in Japan, Offering New Hope for ALS Patients
Eisai Co., Ltd. announced that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has ...
November 21, 2024 | News
Alamar Biosciences and The Michael J. Fox Foundation Partner to Advance Parkinson's Biomarker Discovery
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, is pleased to announce a strategic collaboration w...
November 20, 2024 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
